baber/WOPTO huggingface dataset:
Patent AU-1171600-A (AU)
Title: Compositions and methods for producing vascular occlusion
Inventor: STEWART MICHAEL
IPC: A61K47/48
Filed: 1999-11-10
Abstract: The present invention relates generally to methods and compositions for treating a disease or condition by administering a first therapeutic protocol comprising targeting and delivering solid-phase platelet-dependent vascular occlusion agents, and administering at least one second therapeutic composition or method.
Patent AU-1211595-A (AU)
Title: Modular concrete form system and method for constructing concrete walls
Inventor: HARKENRIDER THOMAS E
IPC: E04G11/10
Filed: 1994-11-22
Abstract: A system for forming architectural concrete walls, comprises a plurality of modular form units, each form unit comprising a generally rectangular support frame, a backing sheet and an overlying facing sheet, each facing sheet having a facing surface defined by a plastic material, an elastic seal along an edge of the form unit for positioning between adjacent form units for preventing water leakage, a minimal number of tie holes extending through the each form unit, a seal tube assembly for positioning between the tie holes, and a tie rod for each tie hole.
Patent AU-1214100-A (AU)
Title: Methods of hydrating mucosal surfaces
Inventor: BOUCHER RICHARD C JR
IPC: A61K47/48
Filed: 1999-10-20
Abstract: A method of hydrating nasal airway surfaces in a subject in need of such treatment comprises topically applying a sodium channel blocker to a nasal airway surface of the subject in an amount effective to inhibit the reabsorption of water by the surface. The channel blocker may be a pyrazinoylguanidine sodium channel blocker, such as benzamil, phenamil, amiloride, or a pharmaceutically acceptable salts thereof. The method may further comprise the step of topically applying a P2Y<SUB>2 </SUB>receptor agonist to a nasal airway surface of the subject in an amount effective to stimulate chloride secretion by the nasal airway surface. In a preferred embodiment, the sodium channel blocker is a covalent conjugate of a pyrazinoylguanidine sodium channel blocker and a non-absorbable carrier moiety (e.g., albumin, polyethylene glycol). Such compounds may also be administered to other mucosal surfaces where it is desired to inhibit the reabsorption of water.
Patent AU-1383895-A (AU)
Title: A layered, absorbent structure, an absorbent article comprising the structure, and a method for the manufacture thereof
Inventor: PALUMBO GIANFRANCO
IPC: A61F13/15
Filed: 1994-12-19
Abstract: PCT No. PCT/EP94/04215 Sec. 371 Date Nov. 21, 1996 Sec. 102(e) Date Nov. 21, 1996 PCT Filed Dec. 19, 1994 PCT Pub. No. WO95/17868 PCT Pub. Date Jul. 6, 1995Disclosed is a thin, layered, absorbent structure comprising first and second layers of fibrous material and an intermediate layer comprising particles of a hydrogelling, absorbent material, in an amount exceeding 120 g/m2, and particles of a thermoplastic, polymeric, organic material; the first and second fibrous layers extend beyond the intermediate layer laterally to form longitudinal edge portions. The two fibrous layers are bound together with the intermediate layer between them by the melting of the particles of thermoplastic, polymeric, organic material and by means of a continuous line of adhesive extending longitudinally on each longitudinal edge portion.
Patent AU-1454502-A (AU)
Title: Ige receptor antagonists
Inventor: LOWMAN HENRY B
IPC: A61P17/02
Filed: 2001-09-26
Abstract: The invention provides novel compounds which bind to the high affinity receptor for immunoglobulin E (IgE) designated FcepsilonRI and methods for identifying and preparing such compounds. In particular aspects, the invention provides to the treatment of disorders mediated by IgE utilizing the novel compounds of the invention. The invention also provides composition, such as pharmaceutical compositions, comprising the novel compounds, as well as for their use in research, diagnostic, therapeutic, and prophylactic methods.
Patent AU-1489488-A (AU)
Title: Plaster containing active ingredients for controlled administration of active ingredients to the skin
Inventor: BARTH PETER
IPC: A61M36/00
Filed: 1988-03-22
Abstract: A plaster containing active ingredients for controlled administration of active ingredients to the skin and possessing a rear side and a skin side, has a rear layer, an active ingredient reservoir containing one or more active ingredients arranged essentially perpendicular to the surface of the plaster in contact with the skin, and an adhesive device on the skin side and possibly a covering layer which is detached before application of the plaster. At least one active ingredient reservoir part (12) can be detached on to the skin while one or more active ingredient reservoir parts remain. For this purpose, the part (13) of the active ingredient reservoir remaining on the skin adheres more strongly to the skin than to the rear side (11).
Patent AU-1505299-A (AU)
Title: Apparatus for producing ozone water and method of producing ozone water by usingthe same apparatus
Inventor: TERADA MITUO
IPC: C25B9/19
Filed: 1998-12-09
Abstract: An ozonized water generating device in which an inside of a casing is defined by a solid electrolyte film into an anode chamber and a cathode chamber, an anode electrode made of noble metal having an ozone generating catalyst function is arranged to be impressed against said solid electrolyte film at said anode chamber, a cathode electrode is arranged to be impressed against said solid electrolyte film at said cathode chamber, respectively, each of said anode chamber and said cathode chamber is provided with a raw water flow inlet port and an electrolized water flow outlet port, and a DC voltage is applied between said anode electrode and said cathode electrode, wherein either one of or both said anode electrode and said cathode electrode are arranged in such a way that they can be impressed against and separated from said solid electrolyte film by a movable driving means. An impressing force of the electrodes against the solid electrolyte film is increased to improve an electrolys is performance with the solid electrolyte film having reduced film performance, the electrodes are depressed from the solid electrolyte film to recover a deteriorated performance of the film to enable its repetitive use to be carried out. <IMAGE>
Patent AU-1603997-A (AU)
Title: Transmission equipment for an interexchange connection
Inventor: LEHTIMAKI MATTI
IPC: H04J3/16
Filed: 1997-02-04
Abstract: PCT No. PCT/FI97/00062 Sec. 371 Date Oct. 7, 1997 Sec. 102(e) Date Oct. 7, 1997 PCT Filed Feb. 4, 1997 PCT Pub. No. WO97/29566 PCT Pub. Date Aug. 14, 1997A compression method and apparatus for a transmission link in a telecommunications network between switching centers each associated with a compression apparatus connected thereto by a number of PCM transmission channels for receiving a speech signal from each PCM transmission channel and transferring the speech signal via an interconnecting PCM link having a transmission capacity lower than the number of transmission channels received from the switching center to the other compression apparatus. The speech signal between the first switching center and the compression apparatus is either a pure PCM coded speech signal or a PCM coded speech signal in which one or more least significant bits of the PCM samples provide a sub-channel for lower-rate vocoded speech containing the same speech information as the PCM samples but in a vo-coded format. The interconnecting link has one or more PCM channels in each of which all bits of the PCM samples are utilized for providing two or more subchannels in each of which lower-rate vocoded speech or data can be transmitted. One compression apparatus is arranged, in response a PCM coded speech signal containing the subchannel, to multiplex the content of the subchannel into one of the subchannels in the interconnecting link, and, in response to a pure PCM coded speech signal, to encode the latter into a lower-rate vocoded speech signal and to multiplex the vocoded speech signal into one of the subchannels in the interconnecting link.
Patent AU-1713600-A (AU)
Title: Silane copolymer coatings
Inventor: TERRY RICHARD N
IPC: C09D201/00
Filed: 1999-11-05
Abstract: Provided are silane copolymers formed from one or more polyisocyanates, one or more organo-functional silanes and one or more lubricious polymers having at least two functional groups. The silane copolymers are prepared by reacting one or more polyisocyanates with one or more lubricious polymers having at least two functional groups, which may be the same or different, that are reactive with an isocyanate functional group and with one or more organo-functional silanes having at least two functional groups, which may be the same or different, that are reactive with an isocyanate functional group, and at least one functional group reactive with a silicone rubber substrate. The silane copolymers are useful as coatings for polysiloxane (rubber) and other difficult to coat substrates, especially for medical devices, such as catheters.
Patent AU-1768095-A (AU)
Title: Gemfibrozil containing pharmaceutical compositions
Inventor: FEKETE PAL DR
IPC: A61K9/28
Filed: 1995-04-27
Abstract: A subject matter of the invention are oral solid pharmaceutical compositions containing as active ingredient gemfibrozil and 1 or more conventional pharmaceutical auxiliary agent(s) and a surfactant which contain as surfactant bis-[2-(ethyl)-hexyl]-sodium-sulfosuccinate in an amount of from 0.05 to 0.5% by weight, related to the gemfibrozil content of the composition. A further subject matter of the invention is a process for preparing these compositions.
Patent AU-1913292-A (AU)
Title: Transmission-blocking vaccine against malaria
IPC: A61K38/00
Filed: 1992-05-07
Abstract: The present invention relates to transmission-blocking vaccines against malaria. Vaccines of the present invention contain a recombinant Pfs25 Plasmodium falciparum protein produced by yeast cells and to yeast cells producing the protein. Mice and monkeys inoculated with the yeast-expressed Pfs25 of the present invention have developed antibodies with transmission-blocking activity. The present invention also relates to methods of preventing or treating malarial infections using the vaccines of the present invention.
Patent AU-1914192-A (AU)
Title: Method for establishing an inbound call to the mobile telephone in a cellular mobile telephone network
IPC: H04W8/26
Filed: 1992-06-03
Abstract: PCT No. PCT/FI92/00174 Sec. 371 Date Mar. 9, 1993 Sec. 102(e) Date Mar. 9, 1993 PCT Filed Jun. 3, 1992 PCT Pub. No. WO92/22174 PCT Pub. Date Dec. 10, 1992.A method for setting up an inbound call to a mobile telephone MS in a cellular mobile telephone network. In the method, a mobile switching center (MSC) requests a home location register (HLR) to provide call routing information, the home location register (HLR) in turn requesting routing information from the visitor location register (VLR) within the location area of which the mobile telephone is currently located, and forwards the received roaming number to the switching center (MSC) for routing the call to the switching center of the current location area and further to the called mobile telephone. To avoid superfluous signalling, when the HLR detects a call transfer operation activated for a respective MS to a call transfer number, the HLR initiates independently a new roaming number request with this call transfer number at least in the case that the call transfer number belongs to another MS in the same HLR.
Patent AU-1914792-A (AU)
Title: Electrosurgical and ultrasonic surgical system
Inventor: KLICEK MICHAEL S
IPC: A61M1/00
Filed: 1992-05-04
Abstract: An electrical circuit system which provides electrical energy to a surgical apparatus having ultrasonic fragmentation, aspiration and electrosurgical coagulation capabilities, which system also includes an impedance sensing network and automatic feedback power output control to reduce RF power output as load impedance increases, thereby reducing RF leakage current.
Patent AU-1934495-A (AU)
Title: Formulations for il-11
Inventor: WARNE NICHOLAS W
IPC: A61K38/00
Filed: 1995-02-28
Abstract: The present invention provides novel formulations comprising IL-11 and glycine. Also provided are compositions, both liquid and lyophilized, comprising IL-11 and glycine and optionally, a buffering agent such as histidine and phosphate.
Patent AU-2029892-A (AU)
Title: Tumor associated monoclonal antibody 81av78
IPC: G01N33/574
Filed: 1992-05-14
Abstract: This invention relates to monoclonal antibodies produced by transformed B-cell lines derived from B-cells of cancer patients actively immunized with autologous tumor antigen. These monoclonal antibodies can be used in both diagnostic procedures and therapy for human cancers.
Patent AU-2164701-A (AU)
Title: Toothbrush
Inventor: BROCKER GERD
IPC: A46B5/00
Filed: 2000-11-30
Abstract: A dental cleaning implement such as a toothbrush, having longitudinally disposed first and second parts flexibly joined together. Between the first and second parts is a rotatable member such that when the implement bends the first parts adjacent to the member bear upon the member. The rotatable member has circumferentially disposed relatively softer and harder regions, so that as the member is rotated the parts can be caused to bear compressibly upon selected softer or harder regions.
Patent AU-2376892-A (AU)
Title: Preparation of microparticles
IPC: A61K49/22
Filed: 1992-08-03
Abstract: PCT No. PCT/GB92/01421 Sec. 371 Date Jul. 8, 1994 Sec. 102(e) Date Jul. 8, 1994 PCT Filed Aug. 3, 1992 PCT Pub. No. WO93/02712 PCT Pub. Date Feb. 18, 1993Hollow microcapsules or solid microspheres for use in diagnostic procedures, as well as methods for making the microcapsules, are provided, which are formed by combining a volatile oil with an aqueous phase including a water soluble material such as a starch, modified starch or proteinaceous material, or a polyethylene glycol (PEG) conjugate, to form a primary emulsion. The primary emulsion then is combined with a second oil, to form a secondary emulsion, and the material is permitted to harden and to form microcapsules around a liquid core of the volatile oil. At least part of the volatile oil then may be removed by evaporation to produce hollow microcapsules. Optionally, all of the volatile oil may be removed prior to hardening of the material, which produces solid microspheres. The The microcapsules can be used in a variety of applications for diagnostic purposes and for drug delivery.
Patent AU-2427801-A (AU)
Title: Methods of using randomized libraries of zinc finger proteins for the identification of gene function
Inventor: CASE CASEY CHRISTOPHER
IPC: C12Q1/68
Filed: 2000-12-06
Abstract: The present invention relates to methods of using libraries of randomized zinc finger proteins to identify genes associated with selected phenotypes.
Patent AU-2495484-A (AU)
Title: Apparatus for sterilizing objects with an aqueous hypochlorite solution
Inventor: AUGUSTO PORTA
IPC: A61L2/18
Filed: 1984-02-01
Abstract: PCT No. PCT/EP84/00023 Sec. 371 Date Oct. 3, 1984 Sec. 102(e) Date Oct. 3, 1984 PCT Filed Feb. 1, 1984 PCT Pub. No. WO84/03045 PCT Pub. Date Aug. 16, 1984.This sterilizing apparatus comports an enclosure (1) in which two electrodes (4,5) of an electrochemical cell are supplied by a transformer-rectifier (16) for producing an aqueous NaOCl solution from a NaCl solution. During its production, the solution is distributed over the surfaces to be sterilized of the objects to be sterilized (9) by a circulation pump (7) and a distribution manifold (6) feeding canes (10) and sprinkling heads (11) by vertical distribution pipes (8).
Patent AU-2510601-A (AU)
Title: Use of anionic surfactants in hot foams for eliminating weeds
Inventor: HEROLD CLAUS-PETER DR
IPC: A01N25/16
Filed: 2000-12-12
Abstract: The invention relates to a method for eliminating weeds using hot foam. According to said method, selected anionic surfactants, optionally combined with additional auxiliary agents and additives, are added to the hot foam.
Patent AU-2517488-A (AU)
Title: Method for monitoring acoustic emissions
Inventor: BELCHAMBER RONALD MALCOLM
IPC: G01N29/04
Filed: 1988-11-16
Abstract: A method for monitoring the operating conditions of process plant or machinery comprises the steps of   (a) detecting the sound intensity of the plant or machinery by means of a sound transducer, e.g., a microphone, the output from which is an analogue signal, the intensity of which is proportional to the intensity of the sound in the audio frequency range,   (b) converting the analogue signal to a digital signal, (c) passing the digital signal through a digital band-pass filter to select at least two frequency bands, (d) utilising the signal power in these bands as signal descriptors and putting them into a multivariate pattern recognition procedure, (e) utilising the pattern recognition procedure to develop soft models to characterise the signals recorded and to assign them to a particular category of known operating conditions, (f) again detecting the sound intensity of the process or machinery by means of the sound transducer,   (g) converting the analogue signal to a digital signal, (h) passing the digital signal through a ditigal band-pass filter to select the same frequency bands as in (c), (i) utilising the signal power in these bands as signal descriptors and putting them into a multivariate pattern recognition procedure, and (j) using the soft models as templates, such that when operating conditions repeat themselves they may be recognised, or a change in conditions may be detected. p
Patent AU-2567002-A (AU)
Title: Membrane scaffold proteins
Inventor: SLIGAR STEPHEN G
IPC: G01N33/15
Filed: 2001-11-20
Abstract: Membrane proteins are difficult to express in recombinant form, purify, and characterize, at least in part due to their hydrophobic or partially hydrophobic properties. Membrane scaffold proteins (MSP) assemble with target membrane or other hydrophobic or partially hydrophobic proteins or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; they are improved over liposomes and detergent micelles. In the presence of phospholipid, MSPs form nanoscopic phospholipid bilayer disks, with the MSP stabilizing the particle at the perimeter of the bilayer domain. The particle bilayer structure allows manipulation of incorporated proteins in solution or on solid supports, including for use with such surface-sensitive techniques as scanning probe microscopy or surface plasmon resonance. The nanoscale particles facilitate pharmaceutical and biological research, structure/function correlation, structure determination, bioseparation, and drug discovery.
Patent AU-2696492-A (AU)
Title: Novel plants and processes for obtaining them
Inventor: BIRD COLIN ROGER
IPC: A01H5/00
Filed: 1992-10-14
Abstract: Plants, particularly cereal plants, which have improved ability to synthesise starch at elevated or lowered temperatures and/or to synthesise starch with an altered fine structure are produced by inserting into the genome of the plant (i) a gene(s) encoding a form of an enzyme of the starch or glycogen biosynthetic pathway, particularly soluble starch synthase and/or branching enzyme and/or glycogen synthase, which display an activity which continues to increase over a temperature range over which the activity would normally be expected to decrease, and/or (ii) a gene(s) encoding sense and anti-sense constructs of enzymes of the starch biosynthetic pathway, particularly soluble starch synthase and/or branching enzyme and/or glycogen synthase, which alters the natural ratios of expression of the said enzymes or inserts enzymes with special structural characteristics which alter the natural branching pattern in starch.
Patent AU-2701297-A (AU)
Title: Process for preparing low-molecular ethylene polymers under high pressure
Inventor: MOLL ULRICH
IPC: C08F110/02
Filed: 1997-04-24
Abstract: A process is disclosed for preparing ethylene polymers with a molecular weight Mw (weight average) lower than 20,000 g/mole at temperatures in a range from 200 to 280  DEG C and pressures in a range from 1000 to 3500 bars in the presence of a catalyst system. The catalyst system used contains: (A) a non-bridged substituted or unsubstituted biscyclopentadienyl complex; (B) a metal compound of general formula (I) M<1> (R<1>)r (R<2>)s (R<3>)t, in which M<1> is an alkaline, an alkaline earth metal or a metal of the third main group of the periodic table; R<1> is hydrogen, C1-C10-alkyl, C6-C15-aryl, alkylaryl or arylalkyl with 1 to 10 C atoms in the alkyl radical and 6 to 20 C atoms in the aryl radical; R<2> and R<3> independently represent hydrogen, halogen, C1-C10-alkyl, C6-C15-aryl, alkylaryl, arylalkyl or alkoxy with 1 to 10 C atoms in the alkyl radical and 6 to 20 C atoms in the aryl radical; r is an integer from 1 to 3; and s and t are integers from 0 to 2, the sum r+s+t corresponding to the valency of M<1>; and (C) a metallocene ion-forming compound selected in a group which consists of strong, neutral Lewis acids, ionic compounds with lewis acid cations and ionic compounds with Brönsted acids as cations. Components (A), (B) and (C) are mixed together and after at the latest 5 minutes are dosed in the reactor.
Patent AU-2742892-A (AU)
Title: An anticoagulant substance obtained from urine
IPC: A61K38/00
Filed: 1992-10-29
Abstract: This invention relates to a novel anticoagulant substance in human urine, a process for its preparation and a pharmaceutical composition comprising the said substance for the prevention and/or treatment of diseases related to the disorders in blood coagulation system.
Patent AU-2816484-A (AU)
Title: Valve stem packing assembly
Inventor: CHARLES WILLIAMS PETER
IPC: F16K41/02
Filed: 1984-03-23
Abstract: A valve body has a stem passage rotatably receiving a valve stem. A packing surrounds the stem in the passage and a packing nut threaded on the stem applies axial force to radially expand the packing into sealing engagement with the stem and passage wall. Controlled slippage components interposed between the packing and packing nut allow rotation of the stem and packing nut without any rotational sliding movement against an end face of the packing. A packing support ring engages the end face of the packing adjacent the packing nut and includes a chevron surface for radially expanding the packing. A gland engages the support ring and a pair of reversely positioned spring washers are interposed between the gland and packing nut. During rotation of the stem, packing nut and spring washers, the gland rotates against the packing support ring. The chevron surface of the support ring includes notches for gripping the packing to prevent relative sliding movement therebetween. A handle is attached to the stem by a handle nut, and a spring washer interposed between the handle and handle nut prevents loosening of the handle nut.
Patent AU-3029699-A (AU)
Title: Determination of polymerization/coagulation in a fluid
Inventor: TENGVALL PENTTI
IPC: G01N33/86
Filed: 1999-02-23
Abstract: An analytical method of qualitative and optionally quantitative determination of the occurrence of polymerization/coagulation in a fluid containing polymerizable/coagulable components is described. The method comprises the steps of directing incident beams of electromagnetic radiation through a transparent support on which a film of electrically conducting material is placed, to the back of the film, at angles equal to or greater than the critical angle for total reflection, and measuring changes in the reflected beams due to changes in the surface plasmon resonance angle. Repeated measurements are correlated to the occurrence and magnitude of changes with qualitative and optionally quantitative occurrence of polymerization/coagulation in the fluid. The analytical method is not volume dependent since only one (small) surface of the measuring instrument needs to be in contact with the fluid. Further, the method can also be applied to poorly transparent fluids such as blood.